Affinity Asset Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,090,441
| Closed | -$25.8M | – | 132 |
|
|
2023
Q4 | $25.8M | Sell |
1,090,441
-38,935
| -3% | -$693K | 5.14% | 3 |
|
|
2023
Q3 | $16.8M | Buy |
1,129,376
+79,258
| +8% | +$1.05M | 5.5% | 3 |
|
|
2023
Q2 | $11.5M | Sell |
1,050,118
-33,000
| -3% | -$307K | 4.53% | 8 |
|
|
2023
Q1 | $9.44M | Sell |
1,083,118
-60,413
| -5% | -$484K | 3.63% | 7 |
|
|
2022
Q4 | $7.17M | Sell |
1,143,531
-146,980
| -11% | -$559K | 3.29% | 12 |
|
|
2022
Q3 | $4.52M | Sell |
1,290,511
-81,733
| -6% | -$294K | 2.08% | 23 |
|
|
2022
Q2 | $4.05M | Buy |
1,372,244
+100,000
| +8% | +$239K | 2.22% | 25 |
|
|
2022
Q1 | $3.96M | Buy |
1,272,244
+150,000
| +13% | +$472K | 1.57% | 28 |
|
|
2021
Q4 | $3.79M | Buy |
+1,122,244
| New | +$4.26M | 1.62% | 31 |
|